Neurophysiological differences between patients clinically at high risk for schizophrenia and neurotypical controls – first steps in development of a biomarker

DSpace/Manakin Repository

Neurophysiological differences between patients clinically at high risk for schizophrenia and neurotypical controls – first steps in development of a biomarker

Citable link to this page

 

 
Title: Neurophysiological differences between patients clinically at high risk for schizophrenia and neurotypical controls – first steps in development of a biomarker
Author: Duffy, Frank H.; D’Angelo, Eugene; Rotenberg, Alexander; Gonzalez-Heydrich, Joseph

Note: Order does not necessarily reflect citation order of authors.

Citation: Duffy, Frank H., Eugene D’Angelo, Alexander Rotenberg, and Joseph Gonzalez-Heydrich. 2015. “Neurophysiological differences between patients clinically at high risk for schizophrenia and neurotypical controls – first steps in development of a biomarker.” BMC Medicine 13 (1): 276. doi:10.1186/s12916-015-0516-z. http://dx.doi.org/10.1186/s12916-015-0516-z.
Full Text & Related Files:
Abstract: Background: Schizophrenia is a severe, disabling and prevalent mental disorder without cure and with a variable, incomplete pharmacotherapeutic response. Prior to onset in adolescence or young adulthood a prodromal period of abnormal symptoms lasting weeks to years has been identified and operationalized as clinically high risk (CHR) for schizophrenia. However, only a minority of subjects prospectively identified with CHR convert to schizophrenia, thereby limiting enthusiasm for early intervention(s). This study utilized objective resting electroencephalogram (EEG) quantification to determine whether CHR constitutes a cohesive entity and an evoked potential to assess CHR cortical auditory processing. Methods: This study constitutes an EEG-based quantitative neurophysiological comparison between two unmedicated subject groups: 35 neurotypical controls (CON) and 22 CHR patients. After artifact management, principal component analysis (PCA) identified EEG spectral and spectral coherence factors described by associated loading patterns. Discriminant function analysis (DFA) determined factors’ discrimination success between subjects in the CON and CHR groups. Loading patterns on DFA-selected factors described CHR-specific spectral and coherence differences when compared to controls. The frequency modulated auditory evoked response (FMAER) explored functional CON–CHR differences within the superior temporal gyri. Results: Variable reduction by PCA identified 40 coherence-based factors explaining 77.8 % of the total variance and 40 spectral factors explaining 95.9 % of the variance. DFA demonstrated significant CON–CHR group difference (P <0.00001) and successful jackknifed subject classification (CON, 85.7 %; CHR, 86.4 % correct). The population distribution plotted along the canonical discriminant variable was clearly bimodal. Coherence factors delineated loading patterns of altered connectivity primarily involving the bilateral posterior temporal electrodes. However, FMAER analysis showed no CON–CHR group differences. Conclusions: CHR subjects form a cohesive group, significantly separable from CON subjects by EEG-derived indices. Symptoms of CHR may relate to altered connectivity with the posterior temporal regions but not to primary auditory processing abnormalities within these regions.
Published Version: doi:10.1186/s12916-015-0516-z
Other Sources: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4630963/pdf/
Terms of Use: This article is made available under the terms and conditions applicable to Other Posted Material, as set forth at http://nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of-use#LAA
Citable link to this page: http://nrs.harvard.edu/urn-3:HUL.InstRepos:23845189
Downloads of this work:

Show full Dublin Core record

This item appears in the following Collection(s)

 
 

Search DASH


Advanced Search
 
 

Submitters